Paclitaxel

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 75007-041
  • Application number ANDA216355
  • SPL ID 83b2ce8a-e9d2-4227-94fd-7edf4f942cca
  • SPL set ID 4df3fda6-0b29-420e-ab91-81441ce914ed
  • UNII P88XT4IS4D
  • RxCUI 583214

What the source publishes

Labeler
Ningbo Shuangcheng Pharmaceutical Co., Ltd
Active ingredients
Paclitaxel (aibumin-bound)
Form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:75007-041_83b2ce8a-e9d2-4227-94fd-7edf4f942cca
{
  "name": "Paclitaxel",
  "splId": "83b2ce8a-e9d2-4227-94fd-7edf4f942cca",
  "labels": [
    {
      "setId": "4df3fda6-0b29-420e-ab91-81441ce914ed",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4df3fda6-0b29-420e-ab91-81441ce914ed",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4df3fda6-0b29-420e-ab91-81441ce914ed"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "Ningbo Shuangcheng Pharmaceutical Co., Ltd",
  "finished": true,
  "packaging": [],
  "productId": "75007-041_83b2ce8a-e9d2-4227-94fd-7edf4f942cca",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION",
  "productNdc": "75007-041",
  "deaSchedule": null,
  "genericName": "Paclitaxel (aibumin-bound)",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "PACLITAXEL",
      "strength": "100 mg/100mg"
    }
  ],
  "applicationNumber": "ANDA216355",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20250515",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175085",
      "N0000175592"
    ],
    "unii": [
      "P88XT4IS4D"
    ],
    "rxcui": [
      "583214"
    ],
    "spl_set_id": [
      "4df3fda6-0b29-420e-ab91-81441ce914ed"
    ],
    "pharm_class_pe": [
      "Microtubule Inhibition [PE]"
    ],
    "pharm_class_epc": [
      "Microtubule Inhibitor [EPC]"
    ],
    "manufacturer_name": [
      "Ningbo Shuangcheng Pharmaceutical Co., Ltd"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:75007-041_83b2ce8a-e9d2-4227-94fd-7edf4f942cca"